NEW YORK (GenomeWeb News) – The Genetics and Public Policy Center at Johns Hopkins University said this week that drug maker Eli Lilly has provided the center with $110,000 to study currently regulatory processes for pharmacogenetic drugs and devices.
 
According to GPPC, the study also will identify impediments to pharmacogenetic innovation and adoption by healthcare providers. It also will propose regulatory reforms.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.